Journal article
Co-delivery of PLGA encapsulated invariant NKT cell agonist with antigenic protein induce strong T cell-mediated antitumor immune responses
- Abstract:
-
Antitumor immunity can be enhanced by the coordinated release and delivery of antigens and immune-stimulating agents to antigen-presenting cells via biodegradable vaccine carriers. So far, encapsulation of TLR ligands and tumor-associated antigens augmented cytotoxic T cell (CTLs) responses. Here, we compared the efficacy of the invariant NKT (iNKT) cell agonist α-galactosylceramide (α-GalCer) and TLR ligands (R848 and poly I:C) as an adjuvant for the full length ovalbumin (OVA) in PLGA nanop...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Version of record, pdf, 941.8KB)
-
- Publisher copy:
- 10.1080/2162402X.2015.1068493
Authors
Bibliographic Details
- Publisher:
- Taylor and Francis Publisher's website
- Journal:
- Oncoimmunology Journal website
- Volume:
- 5
- Issue:
- 1
- Pages:
- e1068493
- Publication date:
- 2015-08-12
- Acceptance date:
- 2015-06-27
- DOI:
- EISSN:
-
2162-402X
- ISSN:
-
2162-4011
- Source identifiers:
-
598738
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:598738
- UUID:
-
uuid:f8834c73-8357-4245-b3b1-fb37bf61d2f0
- Local pid:
- pubs:598738
- Deposit date:
- 2016-06-07
Terms of use
- Copyright holder:
- Yusuf Dolen et al
- Copyright date:
- 2015
- Notes:
-
This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted.
If you are the owner of this record, you can report an update to it here: Report update to this record